Journal Report

Journal of Scleroderma and Related Disorders

Download PDF
Journal Information
Journal Title
Journal of Scleroderma and Related Disorders
Publisher
SAGE Publications Ltd
ISSN
2397-1983
E-ISSN
2397-1991
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Systemic sclerosis spectrum from the Egyptian College of Rheumatology: a nationwide observational study
Nevin Hammam, Manal Hassanien, Nermeen N Aziz et al.
2026-7 Vol. 11 Issue 2 Pages e000014
DOI: 10.1136/jsrd-2026-000014
Novel clustering approach to understanding distinct phenotypes of patients with systemic sclerosis
Dinesh Khanna, Mario Ehlers, Lizette Moros et al.
2026-7 Vol. 11 Issue 2 Pages e000041
DOI: 10.1136/jsrd-2026-000041
Pathogenesis of SSc-ILD
Kristina Elizabeth Neergaard Clark
2026-7 Vol. 11 Issue 2 Pages e000036
DOI: 10.1136/jsrd-2026-000036
Association between bosentan and reduced detection of precapillary pulmonary hypertension in systemic sclerosis: evidence from a EUSTAR study
Nicola Farina, Silvia Bellando-Randone, Sebastien Sanges et al.
2026-7 Vol. 11 Issue 2 Pages e000044
DOI: 10.1136/jsrd-2026-000044
VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis
Anna-Maria Hoffmann-Vold, Oliver Distler, Yannick Allanore et al.
2026-7 Vol. 11 Issue 2 Pages e000052
DOI: 10.1136/jsrd-2026-000052
Benchmarking gastrointestinal involvement in systemic sclerosis: practical insights and unmet needs from a tertiary referral centre
Millie Bensimon, John Mclaughlin, Melissa Mandzuk et al.
2026-7 Vol. 11 Issue 2 Pages e000031
DOI: 10.1136/jsrd-2026-000031
Phase II randomised, double-blind, placebo-controlled, dose-ranging study of nemolizumab with an extension period in adult patients with systemic sclerosis: THESSALIA study design and rationale
Oliver Distler, Dinesh Khanna, Robert Spiera et al.
2026-7 Vol. 11 Issue 2 Pages e000027
DOI: 10.1136/jsrd-2026-000027
Olfactory dysfunction in systemic sclerosis: a cross-sectional study and scoping review
Samuel Pichon, Camille Troux, Helene Behal et al.
2026-7 Vol. 11 Issue 2 Pages e000007
DOI: 10.1136/jsrd-2026-000007
A new dawn for autologous haematopoietic stem cell transplantation in systemic sclerosis in the era of cellular therapies
Julia Spierings
2026-7 Vol. 11 Issue 2 Pages e000040
DOI: 10.1136/jsrd-2026-000040
Primary Raynaud’s phenomenon is associated with attention deficit hyperactivity disorder: a cohort study harnessing electronic healthcare records
Michael Hughes, Zsuzsanna Hortobagyi McMahan, Barbara Ruaro et al.
2026-7 Vol. 11 Issue 2 Pages e000030
DOI: 10.1136/jsrd-2026-000030
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 4, 2026 19:45